Balance Sheet

314.5B

Assets

207.9B

Liabilities

106.6B

Equity

Current Assets	139.6B
Cash & Short-Term Investments	30.2B
Receivables	75.3B
Other Current Assets	34.2B
Non-Current Assets	174.8B
Long-Term Investments	1.7B
PP&E	91B
Intangibles	60.4B
Other Non-Current Assets	21.8B

Current Liabilities	169.7B
Accounts Payable	25.6B
Other Current Liabilities	144B
Non-Current Liabilities	38.3B
Long-Term Debt	20.5B
Other Non-Current Liabilities	17.7B

Currency: DKK

	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	14 396	16 923	18 690	18 852	15 638	14 966	12 104	9 597	12 195	13 535
Cash	14 396	16 923	18 690	18 852	15 638	14 966	12 104	9 597	12 195	13 535
Short-Term Investments	1 509	3 542	2 009	0	0	0	0	6 765	10 921	15 838
Total Receivables	17 779	21 613	22 613	21 938	24 836	29 152	32 184	46 799	57 505	75 261
Accounts Receivables	13 041	15 485	20 234	20 165	22 786	24 912	27 734	40 643	50 560	64 770
Other Receivables	4 738	6 128	2 379	1 773	2 050	4 240	4 450	6 156	6 945	10 491
Inventory	11 357	12 758	14 341	15 373	16 336	17 641	18 536	19 621	24 388	31 811
Other Current Assets	1 252	304	2 113	3 917	2 257	697	2 985	2 813	3 185	3 201
Total Current Assets	46 293	55 140	59 766	60 080	59 067	62 456	65 809	85 595	108 194	139 646
PP&E Net	23 136	25 545	30 179	35 247	41 891	50 551	50 269	55 362	66 671	90 961
PP&E Gross	23 136	25 545	30 179	35 247	41 891	50 551	50 269	55 362	66 671	90 961
Accumulated Depreciation	24 348	25 625	27 845	29 414	30 547	33 869	36 417	40 525	44 755	47 622
Intangible Assets	1 378	2 158	2 714	3 325	5 145	5 835	20 657	38 825	46 324	55 942
Goodwill	0	0	0	0	0	0	0	4 346	5 092	4 464
Note Receivable	0	0	689	567	477	1 205	974	630	663	2 112
Long-Term Investments	856	2 150	1 508	1 195	1 296	1 444	1 348	1 078	886	981
Other Long-Term Assets	5 399	6 806	2 683	1 941	2 893	4 121	5 865	8 672	13 427	20 380
Other Assets	0	0	0	0	0	0	0	4 346	5 092	4 464
Total Assets	77 062 N/A	91 799 +19%	97 539 +6%	102 355 +5%	110 769 +8%	125 612 +13%	144 922 +15%	194 508 +34%	241 257 +24%	314 486 +30%
Liabilities
Accounts Payable	4 950	4 927	6 011	5 610	6 756	6 358	5 717	8 870	15 587	25 606
Accrued Liabilities	9 794	11 281	11 051	6 799	7 015	478	598	590	875	600
Short-Term Debt	720	1 073	229	1 694	515	659	6 684	12 862	480	456
Current Portion of Long-Term Debt	0	0	0	0	0	815	775	822	986	6 022
Other Current Liabilities	18 225	23 592	30 145	32 953	39 878	50 673	56 499	76 372	103 012	136 971
Total Current Liabilities	33 689	40 873	47 436	47 056	54 164	58 983	70 273	99 516	120 940	169 655
Long-Term Debt	0	0	0	0	0	3 009	2 897	12 961	24 318	20 528
Deferred Income Tax	7	6	13	846	118	80	2 502	5 271	4 685	6 376
Other Liabilities	3 072	3 951	4 821	4 638	4 648	5 947	5 925	6 014	7 828	11 366
Total Liabilities	36 768 N/A	44 830 +22%	52 270 +17%	52 540 +1%	58 930 +12%	68 019 +15%	81 597 +20%	123 762 +52%	157 771 +27%	207 925 +32%
Equity
Common Stock	530	520	510	500	490	480	470	462	456	451
Retained Earnings	42 244	48 062	47 607	48 855	54 102	58 291	63 589	72 934	80 625	104 522
Treasury Stock	11	10	9	11	11	10	8	6	6	5
Other Equity	2 469	1 603	2 839	471	2 742	1 168	726	2 644	2 411	1 593
Total Equity	40 294 N/A	46 969 +17%	45 269 -4%	49 815 +10%	51 839 +4%	57 593 +11%	63 325 +10%	70 746 +12%	83 486 +18%	106 561 +28%
Total Liabilities & Equity	77 062 N/A	91 799 +19%	97 539 +6%	102 355 +5%	110 769 +8%	125 612 +13%	144 922 +15%	194 508 +34%	241 257 +24%	314 486 +30%
Shares Outstanding
Common Shares Outstanding	4 649	4 658	4 471	4 351	4 251	4 167	4 088	4 015	3 963	4 458

Income Statement Balance Sheet Cash Flow Statement

Novo Nordisk A/S
NYSE:NVO

Balance Sheet

Balance Sheet Decomposition
Novo Nordisk A/S

Balance Sheet
Novo Nordisk A/S

See Also

Company

Help

Tools

Stocks

Novo Nordisk A/S NYSE:NVO

Balance Sheet

Balance Sheet Decomposition Novo Nordisk A/S

Balance Sheet Novo Nordisk A/S

See Also

Company

Help

Tools

Stocks

Novo Nordisk A/S
NYSE:NVO

Balance Sheet Decomposition
Novo Nordisk A/S

Balance Sheet
Novo Nordisk A/S